by Negar Asdaghi, MD, MSc, FRCPC, FAHA
Stroke has launched a monthly podcast, Stroke Alert. Hosted by Dr. Negar Asdaghi, each episode begins by posing key takeaway questions from featured articles in the current issue of Stroke. This is followed by a brief summary and analysis of these articles, as well as an interview with the author of one of these featured articles or with one of the Stroke editors.
Language
🇺🇲
Publishing Since
3/2/2021
Email Addresses
1 available
Phone Numbers
0 available
April 17, 2025
<p class="MsoNormal" style="mso-margin-top-alt: auto;"><span style= "font-size: 11.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Calibri',sans-serif; mso-fareast-font-family: Calibri; color: black;"> On Episode 51 of the Stroke Alert Podcast, host Dr. Negar Asdaghi highlights two articles from the April 2025 issue of Stroke: “</span><a href= "https://www.ahajournals.org/doi/10.1161/STROKEAHA.124.049315"><span style="font-size: 11.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Calibri',sans-serif; mso-fareast-font-family: Calibri;">Clinical Severity and Outcomes in Large Infarcts With Endovascular Therapy: A Post Hoc Analysis of the ANGEL-ASPECT Trial</span></a><span style="font-size: 11.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Calibri',sans-serif; mso-fareast-font-family: Calibri; color: black;">” and “</span><a href= "https://www.ahajournals.org/doi/10.1161/STROKEAHA.124.047092"><span style="font-size: 11.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Calibri',sans-serif; mso-fareast-font-family: Calibri;">Association Between Thrombus Composition and Etiology in Patients With Acute Ischemic Stroke Treated by Thrombectomy</span></a><span style= "font-size: 11.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Calibri',sans-serif; mso-fareast-font-family: Calibri; color: black;">.” She also interviews Dr. Roland Veltkamp about the PRESTIGE-AF trial, presented in February at the International Stroke Conference.</span></p> <p class="MsoNormal" style="mso-margin-top-alt: auto;"><span style= "font-size: 11.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Calibri',sans-serif; mso-fareast-font-family: Calibri; color: black;"> For the episode transcript, visit:</span> <a href= "https://www.ahajournals.org/do/10.1161/podcast.20250414.579089"><span style="font-size: 11.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Calibri',sans-serif; mso-fareast-font-family: Calibri;"> https://www.ahajournals.org/do/10.1161/podcast.20250414.579089</span></a></p>
March 20, 2025
<p class="MsoNormal" style="mso-margin-top-alt: auto;"><span style= "font-size: 11.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Calibri',sans-serif; mso-fareast-font-family: Calibri; color: black;"> On Episode 50 of the Stroke Alert Podcast, host Dr. Negar Asdaghi highlights two articles from the March 2025 issue of Stroke: “</span><a href= "https://www.ahajournals.org/doi/full/10.1161/STROKEAHA.124.047739"><span style="font-size: 11.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Calibri',sans-serif; mso-fareast-font-family: Calibri;">Impact of Subarachnoid Hemorrhage on Human Glymphatic Function: A Time-Evolution Magnetic Resonance Imaging Study</span></a><span style= "font-size: 11.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Calibri',sans-serif; mso-fareast-font-family: Calibri; color: black;">” and “</span><a href= "https://www.ahajournals.org/doi/full/10.1161/STROKEAHA.124.048536"><span style="font-size: 11.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Calibri',sans-serif; mso-fareast-font-family: Calibri;">Thrombolysis for Ischemic Stroke Beyond the 4.5-Hour Window: A Meta-Analysis of Randomized Clinical Trials</span></a><span style= "font-size: 11.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Calibri',sans-serif; mso-fareast-font-family: Calibri; color: black;">.” She also interviews Drs. Mayank Goyal and Michael Hill about the ESCAPE-MeVO trial, presented in February at the International Stroke Conference.</span></p> <p class="MsoNormal" style="mso-margin-top-alt: auto;"><span style= "font-size: 11.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Calibri',sans-serif; mso-fareast-font-family: Calibri; color: black;"> For the episode transcript, visit:</span> <a href= "https://www.ahajournals.org/do/10.1161/podcast.20250314.838310"><span style="font-size: 11.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Calibri',sans-serif; mso-fareast-font-family: Calibri;"> https://www.ahajournals.org/do/10.1161/podcast.20250314.838310</span></a></p>
February 20, 2025
<p class="MsoNormal" style="mso-margin-top-alt: auto;"><span style= "font-size: 11.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Calibri',sans-serif; mso-fareast-font-family: Calibri; color: black;"> On Episode 49 of the Stroke Alert Podcast, host Dr. Negar Asdaghi highlights two articles from the February 2025 issue of Stroke: “</span><a href= "https://www.ahajournals.org/doi/full/10.1161/STROKEAHA.124.048846"><span style="font-size: 11.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Calibri',sans-serif; mso-fareast-font-family: Calibri;">Safety of Adjunctive Intraarterial Tenecteplase Following Mechanical Thrombectomy: The ALLY Pilot Trial</span></a><span style= "font-size: 11.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Calibri',sans-serif; mso-fareast-font-family: Calibri; color: black;">” and “</span><a href= "https://www.ahajournals.org/doi/full/10.1161/STROKEAHA.124.048654"><span style="font-size: 11.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Calibri',sans-serif; mso-fareast-font-family: Calibri;">Large-Scale Plasma Proteomics Profiles for Predicting Ischemic Stroke Risk in the General Population</span></a><span style= "font-size: 11.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Calibri',sans-serif; mso-fareast-font-family: Calibri; color: black;">.” She also interviews Drs. Tao Wang and Yan Ma about their article “</span><a href= "https://www.ahajournals.org/doi/full/10.1161/STROKEAHA.124.048766"><span style="font-size: 11.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Calibri',sans-serif; mso-fareast-font-family: Calibri;">Determining the Optimal Age for Extracranial-Intracranial Bypass Surgery: A Post Hoc Analysis of the CMOSS Randomized Trial</span></a><span style= "font-size: 11.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Calibri',sans-serif; mso-fareast-font-family: Calibri; color: black;">.”</span></p> <p class="MsoNormal" style="mso-margin-top-alt: auto;"><span style= "font-size: 11.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Calibri',sans-serif; mso-fareast-font-family: Calibri; color: black;"> For the episode transcript, visit:</span> <a href= "https://www.ahajournals.org/do/10.1161/podcast.20250212.411369"><span style="font-size: 11.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Calibri',sans-serif; mso-fareast-font-family: Calibri;"> https://www.ahajournals.org/do/10.1161/podcast.20250212.411369</span></a></p>
American Academy of Neurology
American Academy of Neurology
BMJ Group
Neurology Exam Prep Podcast
NEJM Group
Core IM Team
The Clinical Problem Solvers
The Curbsiders Internal Medicine Podcast
JAMA Network
Brandon Oto, PA-C, FCCM and Bryan Boling, DNP, ACNP, FCCM
JAMA Network
Adam Thomas & Josh Farkas
American Academy of Neurology
American Academy of Neurology
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.